Harm Reduction Therapeutics
banner
hrtherapeutics.bsky.social
Harm Reduction Therapeutics
@hrtherapeutics.bsky.social
The only nonprofit 501(c)(3) pharma company focused on making compassionate 3 mg dosing accessible to as many humans as possible. #StayAliveWithRiVive
https://www.harmreductiontherapeutics.org
The misconception that high doses of naloxone are necessary to reverse a fentanyl overdose can lead to unnecessarily painful precipitated withdrawal symptoms and long-term naloxone avoidance for people who have experienced an overdose (cont in comments).
December 15, 2025 at 7:42 PM
One of HRT’s goals is to reduce the avoidance of naloxone. We believe that by making a compassionate dose that reduces the risk & intensity of precipitated withdrawal, people will be less likely to avoid naloxone or to use drugs alone. (cont. in comments)
November 3, 2025 at 7:27 PM
When naloxone blocks the opioid from reaching the receptors in the brain, breathing is restored, the overdose is reversed, and a life is saved. But this is often a really difficult experience for the person who overdosed, especially when too high a dose of naloxone is used. (cont. in comments)
October 30, 2025 at 2:50 PM
The most compassionate choice you can make is a low dose option like RiVive 3 mg naloxone nasal spray or a 0.4 mg/1ml intramuscular naloxone syringe to reverse an overdose. Let’s not make their experience more distressing by using too much naloxone.🤝
October 6, 2025 at 4:24 PM
Words can hurt, but they can also heal.❤️‍🩹 In harm reduction, the language that reduces stigma matters. Compassionate dosing and compassionate communication go hand in hand.
September 18, 2025 at 2:50 PM
We see caregivers through the eyes of RiVive.🩶 Using a 3 mg naloxone nasal spray has a ripple effect that impacts those who administer it and are responsible for the wellbeing of the person who overdosed. That’s why compassionate dosing matters to the person who’s overdosed and their caregivers.
September 6, 2025 at 2:09 PM